hannahwoolley

158 POSTS 0 COMMENTS

Stroke patients treated at a teaching hospital are less likely to...

Stroke patients appear to receive better care at teaching hospitals with less chance of landing back in hospital during the early stages of recovery,...

Positive US FDA Feedback on its NeuroSTAT traumatic brain injury development...

NeuroVive Pharmaceutical AB has announced positive US Food and Drug Administration (FDA) feedback on its NeuroSTAT clinical development plan for the treatment of moderate to...

Coverage decision extends DRG therapy to 22 million Americans living with...

Abbott has announced a new national coverage determination for the company's dorsal root ganglion (DRG) neurostimulation pain therapy through Aetna. With this coverage decision,...

PathMaker Neurosystems launches European clinical trial of MyoRegulator

PathMaker Neurosystems has announced that it has initiated and successfully enrolled the first patient in its European clinical trial to evaluate MyoRegulator for the non-invasive treatment...

First pass effect…always the goal!

Ischaemic stroke is as quick as it is destructive; minutes, even seconds can be the difference between patients returning to a healthy life or a hindered one....

Penumbra announces acquisition of controlling interest in MVI health

Penumbra, a global healthcare company focused on innovative therapies, has announced it has closed on the acquisition of a controlling interest in its joint...

Penumbra launches JET 7 and Penumbra JET D in USA

Penumbra has announced US commercial availability of the Penumbra JET 7 and Penumbra JET D Reperfusion Catheters powered by the Penumbra ENGINE aspiration source....

Trial shows unprecedented slowing in progressive multiple sclerosis

A drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic (Ohio, USA). Very...

The truth about physician burnout

Writing in the Journal of NeuroInterventional Surgery, Kyle M Fargen (Wake Forest University, Winston-Salem, USA) and Joshua A Hirsch (Massachusetts General Hospital, Boston, USA)...

Wide neck bifurcation aneurysms treated safely in WEB trial

The treatment of wide neck bifurcation aneurysms is more incomplete and dangerous than you think, says Adam Arthur (professor of Neurosurgery, University of Tennessee...

Evidence in favour of DRG stimulation builds with new study

Recent research carried out by Huygen and colleagues in view to being published in Neuromodulation confirms that dorsal root ganglion (DRG) stimulation can significantly...

Aneurysms treated with hydrogel coils have a significantly reduced recurrence rate...

The use of bare platinum coils resulted in aneurysm recurrence in 15.4% of cases compared to just 4.4% (p>0.001) when hydrogel coils were used....

Anxiety and depression may increase the risk of stroke and heart...

Adults ages 45 or older who experience psychological distress such as depression and anxiety may have an increased risk of developing cardiovascular disease, according...

Treatment with ITB therapy vs. oral medication shows quality of life...

The secondary endpoints of the Spasticity In Stroke-Randomised Study (SISTERS) trial, demonstrate Intrathecal Baclofen Therapy (ITB) with baclofen injection reduces spasticity-related pain and improves...

Breastfeeding may help protect mothers against stroke

Breastfeeding is not only good for babies, there is growing evidence it may also reduce the risk for stroke in post-menopausal women who reported breastfeeding at...

US FDA clears first magnetic, non-invasive device treatment for OCD

The US FDA has granted de novo clearance to the first non-invasive device treatment for obsessive compulsive disorder (OCD), BrainsWay’s transcranial magnetic stimulation system,...

Non-invasive brain stimulation may help symptoms of neurodegenerative ataxias

Electrical stimulation of the brain and spinal cord may help treat the symptoms of neurodegenerative ataxias, according to a study published in Neurology. There are several...

Randomised controlled trial needed to determine safety of direct mechanical thrombectomy...

The meta-analysis trial showed no evidence that rates of successful reperfusion differed in direct mechanical thombectomy and intravenous thrombolysis prior to mechanical thrombectomy. In contrast...

US FDA clears non-opioid SPRINT endura and extensa peripheral nerve stimulation...

SPR Therapeutics has announced in a press release that the US Food and Drug Administration (FDA) has cleared its SPRINT endura (single lead) and extensa (dual...

BRAVO flow diverter receives European regulatory approval

CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, has announced it has received European CE mark approval for its BRAVO flow diverter....

Abbott expands its directional deep brain stimulation therapy by offering new...

Parkinson's disease and essential tremor patients can now benefit from upgraded functionality with Abbott's Infinity DBS system. Abbott has announced US Food and Drug...

Mayank Goyal

Mayank Goyal is a professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary, Canada. He is the Director of...

Intellis is now licensed in Canada

Medtronic has announced in a press release that it has received a licence from Health Canada for its Intellis platform, which includes the world's...

Phase 2 clinical trial of NSI-189 in ischaemic stroke initiated

Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, has announced the initiation...

Corindus names Aquilla S Turk as chief medical officer, Neuroendovascular

Corindus Vascular Robotics has announced that Aquilla "Quill" Turk has joined the company as chief medical officer, Neuroendovascular. Turk is a practicing physician at...

Rapid Medical receives CE mark approval for TIGERTRIEVER 13

Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE mark approval for the...

Patent litigation update for Nevro–Boston Scientific case

In a press release, Nevro Corp has announced that it has filed with Boston Scientific a joint statement proposing dismissal of the declaratory judgement claims...

Enrolment of first patient in Phase 3 study of MultiStem treatment...

Athersys has announced that the first patient has been enrolled its Phase 3 study entitled, MultiStem Administration for Stroke Treatment and Enhanced Recovery Study-2...

Blood test might help reduce unnecessary CT scans after traumatic brain...

A high sensitivity blood test might help doctors rule out traumatic intracranial injuries like brain haemorrhage and contusion before resorting to CT scanning, according...

Standardised stroke protocol can ensure ELVO stroke patients are treated within...

A new study shows that developing a standardised stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon...

First ischaemic stroke patients treated with EMBOTRAP II revascularisation device since...

CERENOVUS have announced the first patients have been treated with its new EMBOTRAP II Revascularisation Device since it became commercially available in the US. EMBOTRAP...

Researchers find major inequalities in acute stroke treatment across Europe

Every year, up to 1.3 million people in Europe suffer a first stroke. Acute stroke treatment strategies such as acute treatment of patients in...

First clinical use of the Cascade Dynamic non-occlusive remodeling net announced

Perflow Medical has announced the first clinical cases of the Cascade Dynamic Non-Occlusive Remodeling Net earlier this month by Alejandro Tomasselo at Hospital Vall...

Time delays to thrombectomy for stroke reduce patient lifetime and economic...

Every minute that endovascular thrombectomy (EVT) for a stroke patient is delayed decreases the patient's quality of life and lifespan, and reduces the significant...

New stroke imaging technology could reduce potential for patient brain damage

A new study, presented at the Society of NeuroInterventional Surgery's (SNIS) 15th Annual Meeting, found that new stroke imaging technology could decrease delays in...

Clinical study looking into mechanical thrombectomy for major stroke starts in...

The TENSION research project is to conduct a clinical study to show whether patients affected by severe strokes can also benefit from the mechanical...

Stroke public education campaigns need to raise awareness of TIAs

A new study has found that public messaging for stroke needs to be tailored to include advice on transient ischaemic attacks (TIA) and minor...

Preliminary results of the CRISP study suggest that intraoperative paresthesia mapping...

The CRISP study is looking at patients with chronic back pain. They were implanted with two leads; one using paraesthesia mapping (PM) and the...

Portable device detects severe stroke with 93% sensitivity

The volumetric impedance phase shift spectroscopy (VIPS) device is a portable, noninvasive way of detecting severe stroke, including emergent large vessel occlusion (ELVO), with...

Pre-market approval for Surpass Streamline flow diverter

The US Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline flow diverter to treat unruptured large and giant wide...

Algovita SCS System implantations reach 2,000 in the USA

Nuvectra Corporation, a neurostimulation medical device company, has announced that the Company’s Algovita Spinal Cord Stimulation (SCS) system has been implanted in over 2,000...

Outcomes for contact aspiration and stent retrievers shown to be similar...

The post-hoc analysis of the contact aspiration versus stent retriever for successful revascularisation (ASTER) trial showed that the clot burden score on admission was...

LUNA aneurysm embolisation system similar in safety and efficacy to coiling...

The LUNA aneurysm embolisation system has been found to be safe and effective for the treatment of bifurcation and sidewall aneurysms results, published in...

Level I evidence provided for pain relief from 1 kHz to...

The final of the PROCO trial results showed that patients received equivalent pain relief from 1 kHz to 10 kHz with appropriate neural dosing...

Highly efficient neuroimaging for endovascular mechanical thrombectomy patient triage

Dylan N Wolman and Jeremy J Heit write in NeuroNews about the importance of neuroimaging and the role it plays in patient evaluation. Acute ischaemic...

Nuvectra issues update on US FDA and CE mark applications for...

Nuvectra has issued an update on its US Food and Drug Administration (FDA) pre-market approval (PMA) application and its application for CE mark in...

DBS treatment may slow the progression of parkinson’s tremor in early-stage...

A study at Vanderbilt University Medical Centre, Nashville, USA has provided the first evidence of a treatment that slows the progression of one of...

First-in-man series of the DAISe clot management system intiated

MIVI Neuroscience has announced that it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischaemic stroke. The...

Christopher M Smith joins Neuromod Board as strategic advisor

Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specialising in non-invasive neuromodulation technologies, has announced that Christopher M Smith became Strategic Advisor to...

Adding subcutaneous nerve stimulation allows more effective low back pain relief

Despite the study terminating early due to recruitment difficulties, the results suggest that the addition of subcutaneous nerve stimulation to optimised medical management is...

International study suggests combination therapy may prevent second stroke in certain...

Results from POINT, an international clinical trial of more than 4,880 participants, were presented at the European Stroke Organisation Conference (ESOC; 16-18 May, Gothenberg, Sweden)...

How to treat ischaemic stroke fast: Getting the correct patient to...

“The single biggest challenge going forward is the organisation of stroke care,” says Mayank Goyal (University of Calgary, Canada). He dissected the arguments at...

NeuroNews Issue 30 – US Edition

Highlights WAKE-UP trial shows that thrombolysis can benefit certain stroke patients with unknown time of onset Dylan N Wolman and Jeremy J Heit: Neuroimaging...

NeuroNews Issue 30

Highlights WAKE-UP trial shows that thrombolysis can benefit certain stroke patients with unknown time of onset Dylan N Wolman and Jeremy J Heit: Neuroimaging...

Life-saving stroke educational program goes global

In an effort to improve stroke recognition and reduce life-threatening pre-hospital delays worldwide, an international team lead by researchers at Penn Medicine (Philadelphia, USA)...

Deep brain stimulation associated with a decreased risk of fall in...

Chronic subthalamic deep brain stimulation (DBS) is associated with a decreased risk for recurrent falls and delays the onset of psychosis in patients with...

Thrombectomy in acute stroke therapy: Feasible for very old patients, but...

The mechanical removal of blood clots in acute stroke is highly effective but not suitable for all patients. This is a finding of a...

Focused ultrasound earns positive NICE guidance for treatment of essential tremor

INSIGHTEC has announced that The National Institute for Health and Care Excellence (NICE) issued a positive NICE guidance for unilateral MRI-guided focused ultrasound thalamotomy...

Deep brain stimulation showing promise for patients with mild Alzheimer’s disease...

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most...

New research concludes metric-based simulation helps improve how physicians learn mechanical...

Mentice has welcomed the publication of a research paper in the journal Stroke based on the use of its VIST physics-based, high-fidelity simulator to...

Vesalio reports expansion of commercial distribution and additional published data on...

Vesalio has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System, it has...

US FDA issues draft guidances for recommended premarket testing and labelling...

The US Food and Drug Administration (FDA) released the following two draft guidance documents: These guidance documents provide industry and FDA staff with recommendations on...

New clinician programmer for deep brain stimulation therapy

The US Food and Drug Administration (FDA) has recently approved Medtronic’s state-of-the art Deep Brain Stimulation (DBS) Clinician Programmer and Activa Programming Application, which...

Addressing diverse unmet needs is crucial in reducing high level of...

Addressing the diverse unmet clinical and environmental needs is crucial in reducing the high level of disabilities and stroke recurrence that currently characterise the...

FDA clearance for SOFIA thrombectomy device

MicroVention has announced the US FDA clearance of a new clinical indication for the SOFIA Catheter (Soft TOrqueable catheter For Intracranial Access) to include...

NeuralBot system receives US FDA clearance

Neural Analytics has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its NeuralBot System, a robotic assistance technology...

iSchemaView completes MDSAP audit — moves to expand worldwide adoption of...

iSchemaView has announced that the company has completed the Medical Device Single Audit Program (MDSAP), with coming certification. iSchemaView is now applying for clearances...

ESO and SAFE launch new stroke action plan for Europe: 2018-2030

The action plan provides a clear road map and suggests recommendations and targets for 2030 as an aide to governments. It has the aim...

NAVIGATE ESUS: Trial result shows that rivaroxaban does not prevent recurrent...

Rivaroxaban has been found to be no better than aspirin in reducing the secondary occurrence of cryptogenic stroke and leads to a higher rate...

WAKE-UP trial shows that thrombolysis can benefit certain stroke patients with...

In patients with unknown symptom onset stroke with MRI pattern of DWI-FLAIR-mismatch, treatment with alteplase resulted in better functional outcome than placebo. These benefits...

Stroke survivors could gain the most from new blood pressure guidelines

Treating high blood pressure in stroke survivors more aggressively, could cut deaths by one-third, according to new research in the Journal of the American Heart...

Multicentre study shows Derivo embolisation device to be safe and effective...

Endovascular treatment of unruptured intracranial aneurysms with the Derivo (Acandis) embolisation device is associated with high procedural safety and adequate occlusion rates. All procedures...

Cerus Endovascular promotes Stephen Griffin to president

Cerus Endovascular has announced the promotion of Stephen Griffin to president of the company, effective immediately. Griffin had previously served as the company’s chief...

Expanded two-year follow-up results from the PARADIGM clinical study using CGuard...

Piotr Musiałek, from the Department of Cardiac and Vascular Diseases, John Paul II Hospital, Kraków, Poland, presented the expanded 24-month follow-up results from the...

Aura intracranial pressure monitoring system receives US FDA 510(k) clearance

Branchpoint Technologies has announced that the US Food and Drug Administration has granted 510(k) clearance for its Aura intracranial pressure (ICP) monitoring system. According to...

NeuroPace launches next generation RNS system, the world’s only brain-computer interface...

NeuroPace has announced the launch of its Next Gen RNS System for the treatment of refractory epilepsy. The RNS System is a type of...

Enrolment of ENRICH trial reaches 100 patients

More than 100 patients are now enrolled in the ENRICH randomised controlled trial. The trial is designed to compare the outcomes between early surgical...

MicroVention announces US FDA approval for neuro stent device

MicroVention has announced today the FDA Premarket Approval (PMA) for the LVIS and LVIS Jr. stents for stent-assisted coil embolisation of intracranial aneurysms. The LVIS and LVIS Jr....

Self-tuning brain implant could help treat patients with Parkinson’s disease

This study describes the first fully implanted DBS system that uses feedback from the brain itself to fine-tune its signalling. The study was supported...

Gregory Albers

Gregory Albers has been involved in two of the most transformative studies for stroke patient treatment and care in recent times. Here he speaks...

Final ReActiv8 results: neurostimulation safe and effective treatment for chronic low...

Following implantation of a restorative neurostimulation system significant improvements were observed in pain, disability and quality of life compared to baseline in patients with...

Use of RACE scale may result in faster time to thrombectomy...

By Hannah Woolley The RACE scale has been successfully used by emergency medical services (EMS) agencies to reduce door to arterial puncture times for acute...

Image quality can be maintained while reducing patient radiation dose

By Hannah Woolley Substantial radiation dose reduction (62%) with a live peripheral image can be achieved without compromising feature visibility during neuroendovascular interventions. That is...

Endovascular thrombectomy for mild strokes: How low should we go?

Amrou Sarraj shares his research on the use of thrombectomy for mild strokes and thrombectomy as an appropriate treatment. Recent trials have established that endovascular...

Cerenovus receives US FDA clearance for next generation stent retriever device...

Cerenovus has announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for EMBOTRAP II revascularisation device, a next generation...

State-of-the-art imaging solution provides automated scoring to assess early signs of...

At the European Stroke Organisation Conference, iSchemaView publicly launched RAPID ASPECTS, a digital imaging solution that assists clinicians in assessing early signs of brain...

First neuromate stereotactic robot-assisted procedure in Scotland has taken place

The first Renishaw neuromate stereotactic robot-assisted procedure in Scotland has taken place at The Royal Hospital for Sick Children, Edinburgh. The Royal Hospital for Sick...

The US Department for Homeland Security warns of cybersecurity weakness of...

The US Department of Homeland Security (DHS) has flagged a weakness in the security of a device for programming Medtronic’s neurostimulator implants. Exploiting the...

International study suggests combination therapy may prevent stroke in certain people

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and...

Study lays foundation for treating drug, alcohol addicts with noninvasive brain...

In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first...

Artificial Intelligence improves stroke and dementia diagnosis in commonest form of...

Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan (CT), more...

CE mark for overactive bladder neuromodulation device

StimGuard has received a CE mark for a wireless neuromodulation device to treat chronic symptoms of overactive bladder. “A wireless system that enables urologists to...

New study shows use of EmboTrap device clot retriever during treatment...

A device designed to remove clots from the brain following an ischaemic stroke, the EmboTrap demonstrated high success rates in restoring blood flow and...

Medtronic receives FDA Approval for deep brain stimulation therapy for medically...

Medtronic logo
The US Food and Drug Administration (FDA) has granted premarket approval for Medtronic's deep brain stimulation (DBS) therapy as adjunctive treatment for reducing the...

FDA cautions about risks of coiling for brain aneurysms

After reports of periprocedural stroke and death with the use of neurovascular stents for stent-assisted coiling (SAC), the US FDA issued a safety alert...

Improving mechanical thrombectomy through neuroanatomy

Stroke outcomes can differ by sex. Michael Chen (Rush University Medical Center, Chicago, USA) comments on how differences in neuroanatomy may play a role. Recently...

Hip hop music improves community preparedness for stroke in the USA

The Hip Hope Stroke initiative used hip hop music lyrics to educate economically disadvantaged children and their parents about stroke. Before the initiative, only...

High TICI 2b/3 scores in TREVO registry of ischaemic stroke patients

The Trevo retriever registry showed the overwhelming benefits of stent retrievers to treat acute ischaemic stroke. It found that a final postprocedure TICI score...

How to best detect large vessel occlusion

Detecting large vessel occlusion (LVO) in stroke is essential in providing the correct and most effective treatment. David Ermak (Penn State University, Hershey, USA)...

Trevo retriever becomes first and only device indicated for acute ischaemic...

Following the expanded indication in the USA by the Food and Drug Administration (FDA) in February, the Trevo retriever (Stryker) has received CE marking...

First pass effect is good indicator of overall outcome with mechanical...

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes of the device, 80.2% patients in the study achieved mTICI 2b–3 grade revascularisation in the target vessel. The results were presented at International Stroke Conference (ISC; 24–26 January 2018, Los Angeles, USA)
Achieving complete revascularisation from a single Solitaire (Medtronic) thrombectomy device pass can result in significantly higher rates of good clinical outcomes. These are the...

“Drip-and drive” may be superior to “drip-and-ship”

Transferring interventional neuroradiologists (INR) to primary stroke centres to perform mechanical thrombectomy (“drip-and drive”) is feasible and could result in a significant reduction in...

CT perfusion mismatch for identifying thrombectomy patients

Computerised tomography (CT) perfusion mismatch criteria substantially increases the proportion of patients deemed eligible for thrombectomy compared to clinical core mismatch criteria and, despite...

Positive late-breaking data from the INTREPID study announced

The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...

NeuroNews Issue 29 – US Edition

Highlights DEFUSE 3 shows favourable outcomes for late-window patients and triggers expanded guidelines for treatment eligibility David Ermak: Detecting LVO Profile: Gregory Albers Neuromodulation...

NeuroNews Issue 29

Highlights DEFUSE 3 shows favourable outcomes for late-window patients and triggers expanded guidelines for treatment eligibility David Ermak: Detecting LVO Profile: Gregory Albers Neuromodulation...

Vesalio reports positive results in early NeVa human thrombectomy procedures and...

Vesalio has announced that it has completed European enrolment of the first twenty-five human cases in a post-market registry of the proprietary NeVa neurothrombectomy...

Spinal cord stimulation and chronic pain: In the end it’s about...

Krishnan Chakravarthy writes in NeuroNews about how spinal cord stimulation can be used to treat chronic pain and how this can help America overcome...

Tenecteplase reduces the need for thrombectomy compared to alteplase

Results from the Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK) study show that the use of tenecteplase (0.25mg/kg) led to...

DEFUSE 3 shows favourable outcomes for late-window patients and triggers expanded...

The study results show that endovascular therapy, given alongside standard medical therapy, results in better functional outcome than standard medical therapy alone for ischaemic...

Driving growth of thrombectomy service delivery: The St George’s experience

Advertorial Health services across Europe have now implemented new policies to sustain the development of thrombectomy procedures. England’s National Health Service (NHS England) has made...

New guidelines promote safety for patients on antithrombotic drugs undergoing anaesthesia...

Patient safety is the focus of newly published updates to consensus statements that address the use of antithrombotic drugs by individuals who may require...

Axonics secures US$40M financing to commercialise neuromodulation device

Axonics has secured US$40 million to support commercialisation of its neuromodulatory treatment of urinary and bowel dysfunction. The financing comes as Axonics closes in on the...

Brainomix secures £7m investment to tackle strokes with AI

Brainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted £7m of investment to...

FDA approves septal occluder for PFO closure to prevent recurrent ischaemic...

The REDUCE clinical study demonstrated a 77% relative reduction in recurrent ischaemic stroke when patent foramen ovale (PFO) closure was combined with antiplatelet therapy,...

BioSig announces submission of FDA 510(k) application for PURE EP system

BioSig Technologies has announced that the company has filed 510(k) application to the US Food and Drug Administration (FDA) for its first product, PURE...

Gene therapy may help brain heal from stroke, other injuries

Scientists have found a genetic trigger that may improve the brain’s ability to heal from a range of debilitating conditions, from strokes to concussions...

Stroke affects more than just the physical

A new study looks at what problems affect people most after a stroke and it provides a broader picture than what some may usually...

FDA recalls brain surgery device due to heating problem

The US FDA has alerted doctors to a problem with the Monteris Medical NeuroBlate probe in which the device may become unexpectedly heated during...

Long stent retrievers associated with increased rates of first-pass reperfusion

Longer stent retrievers were found independently associated with higher rates of first-pass reperfusion and should be favoured over their shorter counterparts in light of...

WEAVE trial shows positive results using Wingspan stent system

The final results showed that following on-label indications resulted in extremely low periprocedural stroke and death rate (2.6%) with Wingspan for FDA approved indication....

Optima Coil System receives 510(k) clearance

The Optima Coil System has received 510(k) clearance and has reached completion of the first clinical cases in the United States. The Optima Coil...

The truth about stent retrievers and direct aspiration catheters for mechanical...

We have all heard the story. It goes like this... “Once upon a time there were five brave randomised trials that went out into the...

The burden of stroke: A global perspective

The landscape of stroke care has begun to change as a direct response to the growing research and breakthroughs in the approach to stroke...

FDA approves PulseRider device for marketing

The FDA has approved PulseRider (Cerenovus) device to be marketed. The device is indicated for use with neurovascular embolic coils in patients 18 years...

Pulsante Therapy awarded prestigious Forfait Innovation package to fast-track medical innovation...

Autonomic Technologies has announced that the College of the French National Authority for Health (HAS) issued a favourable opinion on a Forfait Innovation package...

Biogen buys Pfizer’s unwanted neuro med for US$75M

Biogen has bought a phase 2-ready schizophrenia drug. They will pay a US$75 million upfront for the therapy, with a follow-up payment of US$515...

Neurovascular embolisation coils: potential for increased image artifact when using magnetic...

Information reviewed by the FDA, indicates that when magnetic resonance angiography (MRA) is performed on patients implanted with neurovascular embolisation coils containing 304V stainlesss...

RegeneRx receives “decision to grant” European patent for treatment of peripheral...

RegeneRx Biopharmaceuticals has announced that the European Patent Office has issued a decision to grant a new patent for treating patients with peripheral neuropathy...

Soin Neuroscience commences a clinical case series with Nuvectra’s Algovita spinal...

Soin Neuroscience, a biotech company based in Dayton, Ohio, USA, has received IRB (institutional review board) approval to commence a clinical case series to study...

Brain’s immune system is key to recovery from motor neuron degeneration...

Researchers have engineered mice in which the damage caused by a mutant human TDP-43 protein could be reversed by one type of brain immune...

Birth control pills increase risk of ischaemic stroke

Oral contraceptives increase the risk of ischaemic stroke, but this risk is very small among women who do not have other stroke risk factors,...

Brain injury may boost risk of Alzheimer’s earlier in life

Concussions and other traumatic brain injuries may increase the risk of developing Alzheimer’s disease earlier in life, according to a study published in Neuropsychology. The...

Simon Thomson

With a history of medicine in his blood and almost 30 years in the pain management field, Simon Thomson has been at the centre...

TRAIL multicentre study finds LVIS devices safe and effective in aneurysm...

The TRAIL multicentre study has found that the LVIS (Low Profile Visualized Intraluminal Support) and LVIS Jr devices (MicroVention) are safe and effective for...

Neurostimulation can be part of the solution to the opioid crisis

The president of the United States of America has recently declared the opioid crisis in that country a “public health emergency”. In light of...

Shorter treatment times for endovascular therapy with “trip-and-treat” stroke model

A team at Mount Sinai Hospital in New York, USA, has shown that their trip-and-treat model is associated with shorter treatment times for endovascular...

A new approach to mechanical thrombectomy: The SAVE technique

As mechanical thrombectomy continues to be established as the standard of care for the treatment of patients with large vessel occlusion stroke, investigators strive...

New blood test detects traumatic brain injury—not concussion

A new blood test approved by the Food and Drug Administration is being characterised by the agency and news reports as a way to...

Three Rivers Medical receives CE mark for the Rio embolisation coil...

Three Rivers Medical has announced that it has received CE mark (Conformité Européenne) for its Rio embolisation coil system and has successfully treated its first...

Stretchable electronics a “game changer” for stroke recovery treatment

A groundbreaking new wearable sensor designed to be worn on the throat could be a game-changer in the field of stroke rehabilitation. Developed in the lab...

RegeneRX receives Canadian patent for treating neurological injury and damage

RegeneRx Biopharmaceuticals has announced that the Canadian Patent Office has issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment...

Perflow Medical closes US$12 million in financing to treat complex neurovascular...

Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, today announced that the company has closed $12 million in...

FDA expands treatment window for use of clot retrieval devices in...

The US Food and Drug Administration has cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24...

NeuroNews Issue 28 – US Edition

Highlights Two trials validate use of image-based selection for late window stroke patients Global burden of stroke: part one Profile: Simon Thomson Neuromodulation section ...

FDA authorises marketing of first blood test to aid in the...

The US Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to...

“Shuffle” stimulation improves pain scores in pilot study

A pilot study published in Neuromodulation: Technology at the Neural Interface suggests that high frequency stimulation (HFS), an alternative SCS waveform could also be...

Rapid Medical device proves promising for safely supporting aneurysm coiling occlusion

The Comaneci device from Rapid Medical offers a promising and reliable way of safely supporting aneurysm coiling occlusion, even in a rupture environment. That is...

NeuroNews Issue 28

Highlights Two trials validate use of image-based selection for late window stroke patients Global burden of stroke: part one Profile: Simon Thomson Neuromodulation section ...

FDA permits marketing of software that may alert doctors of stroke...

The US Food and Drug Administration have permitted the marketing of the Viz.AI Contact application, a type of clinical decision support software designed to...

Canon Medical Systems’ Vantage Galan 3T XGO Edition receives FDA clearance

Physicians now have access to more neuro and cardiac MR imaging capabilities with the Vantage Galan 3T XGO Edition from Canon Medical Systems USA,...

Eye could provide “window to the brain” after stroke

Research into curious bright spots in the eyes on stroke patients’ brain images could one day alter the way these individuals are assessed and...

ARISE II results show two-thirds of ischaemic stroke patients return to...

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes of the device, 80.2% patients in the study achieved mTICI 2b–3 grade revascularisation in the target vessel. The results were presented at International Stroke Conference (ISC; 24–26 January 2018, Los Angeles, USA)
EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes...

Deep brain stimulation shows promise as treatment for Alzheimer’s disease

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and...

COMPASS study finds ADAPT non-inferior to stent retriever for first-line mechanical...

The COMPASS study has found that the use of ADAPT as first-line mechanical thrombectomy therapy for acute ischaemic stroke results in non-inferior functional outcomes...

Pathway R-1 registry study demonstrates Pulsante therapy effectively treats cluster headaches

Autonomic Technologies, Inc., has announced the publication of results from the Pathway R-1 registry study demonstrating the Pulsante SPG Microstimulator System’s effectiveness in more...

Cerenovus launches next generation embolic coil for treatment of cerebral aneurysms...

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced the launch of the Galaxy G3 mini coil, its smallest and softest...

The Joint Commission, American Heart Association/American Stroke Association announce new thrombectomy...

The Joint Commission, in collaboration with the American Heart Association/American Stroke Association, the world’s leading voluntary health organisation devoted to fighting cardiovascular disease and...